A detailed history of Plato Investment Management LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Plato Investment Management LTD holds 4,020 shares of CDNA stock, worth $82,852. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,020
Previous 3,977 1.08%
Holding current value
$82,852
Previous $61.8 Million 103.03%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$14.41 - $33.99 $619 - $1,461
43 Added 1.08%
4,020 $125 Million
Q2 2024

Aug 08, 2024

BUY
$7.56 - $16.15 $30,066 - $64,228
3,977 New
3,977 $61.8 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.1B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.